LeMaitre Vascular, Inc. (LMAT)
77.65
-1.64
(-2.07%)
USD |
NASDAQ |
Nov 12, 16:00
77.66
+0.02
(+0.02%)
After-Hours: 20:00
LeMaitre Vascular Total Assets (Quarterly) : 656.03M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 656.03M |
| June 30, 2026 | 640.55M |
| March 31, 2026 | 629.53M |
| December 31, 2025 | 615.69M |
| September 30, 2025 | 598.07M |
| June 30, 2025 | 577.59M |
| March 31, 2025 | 556.01M |
| December 31, 2024 | 551.82M |
| September 30, 2024 | 377.02M |
| June 30, 2024 | 363.08M |
| March 31, 2024 | 353.96M |
| December 31, 2023 | 346.78M |
| September 30, 2023 | 334.01M |
| June 30, 2023 | 326.47M |
| March 31, 2023 | 314.87M |
| December 31, 2022 | 310.48M |
| September 30, 2022 | 302.05M |
| June 30, 2022 | 299.42M |
| March 31, 2022 | 292.45M |
| December 31, 2021 | 292.80M |
| September 30, 2021 | 289.47M |
| June 30, 2021 | 246.50M |
| March 31, 2021 | 247.37M |
| December 31, 2020 | 252.81M |
| September 30, 2020 | 261.57M |
| Date | Value |
|---|---|
| June 30, 2020 | 255.72M |
| March 31, 2020 | 184.56M |
| December 31, 2019 | 188.34M |
| September 30, 2019 | 170.01M |
| June 30, 2019 | 162.66M |
| March 31, 2019 | 160.25M |
| December 31, 2018 | 153.09M |
| September 30, 2018 | 144.33M |
| June 30, 2018 | 137.10M |
| March 31, 2018 | 129.41M |
| December 31, 2017 | 126.32M |
| September 30, 2017 | 121.27M |
| June 30, 2017 | 112.05M |
| March 31, 2017 | 106.52M |
| December 31, 2016 | 101.92M |
| September 30, 2016 | 101.31M |
| June 30, 2016 | 95.53M |
| March 31, 2016 | 93.38M |
| December 31, 2015 | 90.70M |
| September 30, 2015 | 86.61M |
| June 30, 2015 | 83.24M |
| March 31, 2015 | 79.57M |
| December 31, 2014 | 81.49M |
| September 30, 2014 | 83.50M |
| June 30, 2014 | 80.54M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Abbott Laboratories | 108.25B |
| AngioDynamics, Inc. | 241.93M |
| Alphatec Holdings, Inc. | 796.74M |
| AtriCure, Inc. | 717.54M |
| Baxter International, Inc. | 19.41B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 223.90M |
| Shareholders Equity (Quarterly) | 432.13M |
| Debt to Equity Ratio | 0.437 |
| Current Ratio | 14.19 |
| Net Debt Paydown Yield | -0.03% |